An online clinic’s name may appear on every page you read, while the medicine and pharmacy receive much less attention. They are different parts of the care arrangement. Knowing which organization does what makes it easier to understand a prescription and direct a question to the right professional.

This guide explains what to clarify before starting a proposed testosterone medicine. It uses regulatory information, prescribing labels, and provider pages checked September 22, 2026. It does not recommend a product, compare doses, or supply instructions for using medication.

KEEP IN MIND

A few things to remember.

  • The clinic brand, clinician, medicine, and dispensing pharmacy can be different entities.
  • Compounded preparations are not FDA-approved finished products.
  • Use the exact prescription label and professional instructions, not another product’s directions.

Ask for the full product description

Request the medicine’s name, formulation, route, strength, and dispensing pharmacy. Testosterone is an ingredient name, while the finished product carries its own instructions and regulatory status. An injectable product such as Depo-Testosterone and a topical product such as AndroGel 1.62% have different labels; neither label proves that an online service uses that product.

Ask why the proposed formulation fits the clinical assessment and what practical responsibilities come with it. Do not copy another person’s directions or assume a change of route is a simple substitution. The prescribing clinician and pharmacist should resolve discrepancies between what you expected and what the label says.

Sources: Pfizer: Depo-Testosterone prescribing information · DailyMed: AndroGel 1.62% prescribing information

Clarify whether the preparation is compounded

Compounded drugs are not FDA-approved. The FDA does not review them for safety, effectiveness, and quality before marketing in the way it reviews approved drugs. Compounding can address particular patient needs, but a familiar ingredient or licensed pharmacy does not make a compounded finished preparation approved.

Ask why compounding is being proposed in your case and whether an approved option is appropriate. This is a request for a clinical explanation, not a claim that every compounded medicine is interchangeable or that every patient needs one. Keep the answer with the product details so you can revisit it if treatment changes.

Sources: FDA: understanding the risks of compounded drugs

Know who answers which question

The service arranging appointments, the clinician making treatment decisions, and the pharmacy dispensing a prescription may be separate organizations. Ask for the relevant names and contact methods. If a label, package, or supply looks different from what was discussed, you should know how to reach someone able to address that specific concern.

Ask the pharmacist about product-specific storage, handling, disposal, and missing or damaged supplies. Ask the prescriber about the treatment rationale and clinical changes. Do not improvise a replacement instruction from a review article or another provider’s website; the exact preparation matters.

Sources: FDA: understanding the risks of compounded drugs

Keep pharmacy details separate from a subscription promise

Henry Meds describes compounded and named oral options, AlphaMD describes medication and supplies in its plans, and TRT Nation describes a compounding supply model in its FAQ. Those statements support questions about the offers, but they do not establish the exact prescription and pharmacy for every reader.

Our Henry review, AlphaMD review, and TRT Nation review preserve those boundaries. For CoreAge Rx, a current TRT service, product, pharmacy, and price remain unverified. Promotional placement should never be used to fill in missing dispensing information.

Sources: Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ · AlphaMD: current payment terms and assessment process · TRT Nation: laboratory costs, state access, and clinical process

Bring household routines into the discussion

Topical testosterone can create a risk of unintended exposure to another person. AndroGel 1.62% carries a boxed warning about secondary exposure, with product-specific precautions. Different gels and creams can have different application instructions, so a general preference for topical treatment is only the beginning of the practical conversation.

Our household-safety guide explains the questions to discuss if a topical medicine is proposed. Tell the clinician about regular close contact with children or other household members and ask how the exact product’s instructions fit your routine. Do not transfer one label’s directions to another preparation.

Sources: DailyMed: AndroGel 1.62% prescribing information

Ask what continues after dispensing

Receiving medication does not complete the clinical assessment or remove the need for follow-up. Ask how the prescriber will evaluate benefit, possible adverse effects, blood pressure, blood counts, and other individual considerations. Fertility goals should be discussed before testosterone treatment, because sperm production can be suppressed.

The follow-up guide helps organize those responsibilities. Keep a record of the product and pharmacy along with your appointment information. If the formulation or dispensing arrangement changes, ask for a fresh explanation rather than assuming every earlier instruction still applies.

Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes

Sources you can check

Provider pages describe commercial offers. Medical references provide context. Checked September 22, 2026; prices and availability can change.

  1. Pfizer: Depo-Testosterone prescribing information
  2. DailyMed: AndroGel 1.62% prescribing information
  3. FDA: understanding the risks of compounded drugs
  4. Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
  5. AlphaMD: current payment terms and assessment process
  6. TRT Nation: laboratory costs, state access, and clinical process
  7. Endocrine Society: testosterone therapy clinical guidance
  8. FDA: 2025 testosterone labeling and blood pressure changes

Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.